AU8764191A - Ibuprofen-antihistamine combinations - Google Patents
Ibuprofen-antihistamine combinationsInfo
- Publication number
- AU8764191A AU8764191A AU87641/91A AU8764191A AU8764191A AU 8764191 A AU8764191 A AU 8764191A AU 87641/91 A AU87641/91 A AU 87641/91A AU 8764191 A AU8764191 A AU 8764191A AU 8764191 A AU8764191 A AU 8764191A
- Authority
- AU
- Australia
- Prior art keywords
- ibuprofen
- antihistamine
- combinations
- antihistamine combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58924190A | 1990-09-28 | 1990-09-28 | |
US58924590A | 1990-09-28 | 1990-09-28 | |
US589241 | 1990-09-28 | ||
US589245 | 1990-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8764191A true AU8764191A (en) | 1992-04-28 |
Family
ID=27080486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87641/91A Abandoned AU8764191A (en) | 1990-09-28 | 1991-09-25 | Ibuprofen-antihistamine combinations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0550668A4 (en) |
JP (1) | JPH06502166A (en) |
AU (1) | AU8764191A (en) |
CA (1) | CA2092566A1 (en) |
WO (1) | WO1992005783A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663819A4 (en) * | 1992-09-29 | 1998-05-27 | Merck & Co Inc | Ibuprofen-caffeine combinations. |
BR9307697A (en) * | 1992-12-21 | 1999-05-25 | Procter & Gamble | Compositions containing caffeine and s (+) - ibuprofen or s (+) - flubiprofen or s (+) - quetoprofen |
HU222887B1 (en) * | 1993-10-25 | 2003-12-29 | Merrell Pharmaceuticals Inc. | A stable pharmaceutical composition of terfenadine and ibuprofen |
WO1995025518A1 (en) * | 1994-03-18 | 1995-09-28 | Ciba-Geigy Ag | Aqueous solution of levocabastine for ophthalmic use |
JPH11510168A (en) * | 1995-07-28 | 1999-09-07 | ザ、プロクター、エンド、ギャンブル、カンパニー | Compositions and methods containing analgesics and antihistamines for treating respiratory disorders |
JP4614638B2 (en) * | 2002-06-07 | 2011-01-19 | 第一三共株式会社 | Analgesic composition |
JP4614640B2 (en) * | 2002-07-04 | 2011-01-19 | 第一三共株式会社 | Antipyretic composition |
JP2010159299A (en) * | 2002-07-04 | 2010-07-22 | Daiichi Sankyo Co Ltd | Antipyretic composition comprising loxoprofen and ketotifen |
US8771643B2 (en) | 2008-01-04 | 2014-07-08 | Schabar Research Associates Llc | Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound |
KR20110017365A (en) * | 2008-05-30 | 2011-02-21 | 페어필드 클리니컬 트라이얼즈 엘엘씨 | Method and composition for skin inflammation and discoloration |
DK2853262T3 (en) | 2009-10-26 | 2017-03-06 | Sephoris Pharmaceuticals Llc | Treatment of sunburn using analgesics and antihistamines |
IL254641B2 (en) | 2015-03-26 | 2024-01-01 | Jacqueline M Iversen | Methods and compositions comprising naproxen and fexofenadine to inhibit symptoms of dizziness associated with intake of alcohol |
CN116194102A (en) | 2020-07-15 | 2023-05-30 | 沙巴研究联合有限责任公司 | Unit oral dosage composition comprising ibuprofen and famotidine for treating acute pain and reducing the severity and/or risk of heartburn |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
US20240000734A1 (en) * | 2020-12-04 | 2024-01-04 | Laboratorios Silanes S.A. De C.V. | Pharmaceutical composition having an analgaesic and an antihistamine for treating respiratory diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783465A (en) * | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
ES2055685T3 (en) * | 1986-11-14 | 1994-09-01 | Puetter Medice Chem Pharm | PROCEDURE FOR OBTAINING A MEDICINAL PRODUCT CONTAINING IBUPROFEN. |
US4851444A (en) * | 1987-07-10 | 1989-07-25 | Analgesic Associates | Onset-hastened/enhanced analgesia |
US4980375A (en) * | 1987-07-10 | 1990-12-25 | Sterling Drug Inc. | Onset-hastened/enhanced antipyretic response |
-
1991
- 1991-09-25 JP JP3517917A patent/JPH06502166A/en active Pending
- 1991-09-25 CA CA002092566A patent/CA2092566A1/en not_active Abandoned
- 1991-09-25 AU AU87641/91A patent/AU8764191A/en not_active Abandoned
- 1991-09-25 WO PCT/US1991/007007 patent/WO1992005783A1/en not_active Application Discontinuation
- 1991-09-25 EP EP19910918783 patent/EP0550668A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0550668A4 (en) | 1993-10-13 |
EP0550668A1 (en) | 1993-07-14 |
WO1992005783A1 (en) | 1992-04-16 |
CA2092566A1 (en) | 1992-03-29 |
JPH06502166A (en) | 1994-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU639126B2 (en) | Oxorapamycin | |
AU8791591A (en) | Tnf-muteins | |
AU7846991A (en) | Aminobenzodiazepines | |
AU7867491A (en) | Compounds | |
AU8764191A (en) | Ibuprofen-antihistamine combinations | |
AU7956191A (en) | Transportsystem | |
AU7804691A (en) | N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas | |
AU9030991A (en) | Improved capacitor-sensor | |
AU1556892A (en) | 2-substituted-2-imidazolines | |
AU1080292A (en) | Ige-receptor-antibodies | |
AU7726391A (en) | Slitterscorer | |
AU8017991A (en) | Structural elements | |
AU1766292A (en) | Ibuprofen-decongestant combinations | |
AU6531090A (en) | Swagable fitting | |
AU8624791A (en) | Compounds | |
AU6498390A (en) | Improved packerhead assembly | |
AU8740291A (en) | 3d-spectacles | |
AU7566691A (en) | Compostor | |
AU7587991A (en) | Electrodermatome | |
AU8984191A (en) | Thiadiazinones | |
AU8516291A (en) | Instant photograph-postcard | |
AU7752291A (en) | Stay | |
AU7709991A (en) | Phenoxyphenylsulphonyl compounds | |
AU8710691A (en) | Ibuprofen-diuretic combinations | |
AU7922191A (en) | 2-acylamino-7-chlorobenzothiazoles |